Skip to main content
EJNMMI Radiopharmacy and Chemistry
EJNMMI Radiopharmacy and Chemistry Cover Image

Articles

Page 1 of 5

  1. Platelet-derived growth factor receptor beta (PDGFRβ) is a receptor overexpressed on activated hepatic stellate cells (aHSCs). Positron emission tomography (PET) imaging of PDGFRβ could potentially allow the q...

    Authors: Olivia Wegrzyniak, Bo Zhang, Johanna Rokka, Maria Rosestedt, Bogdan Mitran, Pierre Cheung, Emmi Puuvuori, Sofie Ingvast, Jonas Persson, Helena Nordström, John Löfblom, Fredrik Pontén, Fredrik Y. Frejd, Olle Korsgren, Jonas Eriksson and Olof Eriksson
    Citation: EJNMMI Radiopharmacy and Chemistry 2023 8:23
    Content type: Research article Published on:

  2. Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy which may benefit from radioimmunotherapy. Previously, [177Lu]Lu-DOTA-C595 has been developed as a beta-emitting radioimmunoconjugate to target ...

    Authors: Ashleigh Hull, William Hsieh, Artem Borysenko, William Tieu, Dylan Bartholomeusz and Eva Bezak
    Citation: EJNMMI Radiopharmacy and Chemistry 2023 8:22
    Content type: Research article Published on:

  3. Peptidic radiotracers are preferentially excreted through the kidneys, which often results in high persistent renal retention of radioactivity, limiting or even preventing therapeutic clinical translation of t...

    Authors: Belinda Trachsel, Giulia Valpreda, Alexandra Lutz, Roger Schibli, Linjing Mu and Martin Béhé
    Citation: EJNMMI Radiopharmacy and Chemistry 2023 8:21
    Content type: Research article Published on:

  4. Imaging of cell death can provide an early indication of treatment response in cancer. [99mTc]Tc-Duramycin is a small-peptide SPECT tracer that recognizes both apoptotic and necrotic cells by binding to phosphati...

    Authors: Taco Metelerkamp Cappenberg, Stijn De Schepper, Christel Vangestel, Stef De Lombaerde, Leonie wyffels, Tim Van den Wyngaert, Jeffrey Mattis, Brian Gray, Koon Pak, Sigrid Stroobants and Filipe Elvas
    Citation: EJNMMI Radiopharmacy and Chemistry 2023 8:20
    Content type: Research article Published on:

  5. The liver is a common site for metastatic disease for a variety of cancers, including colorectal cancer. Both primary and secondary liver tumors are supplied through the hepatic artery while the healthy liver ...

    Authors: Anders Josefsson, Angel G. Cortez, Harikrishnan Rajkumar, Joseph D. Latoche, Ambika P. Jaswal, Kathryn E. Day, Mohammadreza Zarisfi, Lora H. Rigatti, Ziyu Huang and Jessie R. Nedrow
    Citation: EJNMMI Radiopharmacy and Chemistry 2023 8:19
    Content type: Research article Published on:

  6. Pancreatic ductal adenocarcinoma (PDAC) continues to be a malignancy with an unmet clinical demand. Development of radioimmunoconjugates which target cancer-specific receptors provides an opportunity for radio...

    Authors: Ashleigh Hull, William Hsieh, William Tieu, Dylan Bartholomeusz, Yanrui Li and Eva Bezak
    Citation: EJNMMI Radiopharmacy and Chemistry 2023 8:18
    Content type: Research article Published on:

  10. A family of BF2-chelated tetraaryl-azadipyrromethenes was developed as non-porphyrin photosensitizers for photodynamic therapy. Among the developed photosensitizers, ADPM06 exhibited excellent photochemical and p...

    Authors: Kazunori Kawamura, Tomoteru Yamasaki, Masayuki Fujinaga, Tomomi Kokufuta, Yiding Zhang, Wakana Mori, Yusuke Kurihara, Masanao Ogawa, Kaito Tsukagoe, Nobuki Nengaki and Ming-Rong Zhang
    Citation: EJNMMI Radiopharmacy and Chemistry 2023 8:14
    Content type: Research article Published on:

  11. The [177Lu]Lu-DOTA-TATE mediated peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors (NETs) is sometimes leading to treatment resistance and disease recurrence. An interesting alternative could ...

    Authors: Maryana Handula, Savanne Beekman, Mark Konijnenberg, Debra Stuurman, Corrina de Ridder, Frank Bruchertseifer, Alfred Morgenstern, Antonia Denkova, Erik de Blois and Yann Seimbille
    Citation: EJNMMI Radiopharmacy and Chemistry 2023 8:13
    Content type: Research article Published on:

  13. Ketones are increasingly recognized as an important and possibly oxygen sparing source of energy in vital organs such as the heart, the brain and the kidneys. Drug treatments, dietary regimens and oral ketone ...

    Authors: Thien Vinh Luong, Erik Nguyen Nielsen, Lise Falborg, Mette Louise Gram Kjærulff, Lars Poulsen Tolbod, Esben Søndergaard, Niels Møller, Ole Lajord Munk and Lars Christian Gormsen
    Citation: EJNMMI Radiopharmacy and Chemistry 2023 8:12
    Content type: Research article Published on:

  14. 177Lu-radiopharmaceuticals are routinely used for the treatment of various tumor entities. The productions of radiopharmaceuticals follow strict good-manufacturing practice guidelines and synthesis optimizations ...

    Authors: Aylin Cankaya, Matthias Balzer, Holger Amthauer, Winfried Brenner and Sarah Spreckelmeyer
    Citation: EJNMMI Radiopharmacy and Chemistry 2023 8:10
    Content type: Research article Published on:

  15. The radionuclide Ga-68 is commonly used in nuclear medicine, specifically in positron emission tomography (PET). Recently, the interest in producing Ga-68 by cyclotron irradiation of [68Zn]Zn nitrate liquid targe...

    Authors: Svenja Trapp, Tom Lammers, Gokce Engudar, Cornelia Hoehr, Antonia G. Denkova, Elisabeth Paulssen and Robin M. de Kruijff
    Citation: EJNMMI Radiopharmacy and Chemistry 2023 8:9
    Content type: Research article Published on:

  16. CD70-CD27 is a costimulatory ligand-receptor pair in the tumor necrosis factor receptor family. With only limited expression in normal tissues, CD70 is constitutively expressed in a variety of solid tumors and...

    Authors: Jonatan Dewulf, Tal Flieswasser, Tim Delahaye, Christel Vangestel, Alan Miranda, Hans de Haard, Julie Jacobs, Evelien Smits, Tim Van den Wyngaert and Filipe Elvas
    Citation: EJNMMI Radiopharmacy and Chemistry 2023 8:8
    Content type: Research article Published on:

  17. Targeted radionuclide therapy with [177Lu]Lu-PSMA I&T (zadavotide guraxetan) has proven high efficacy and safety in treating patients with advanced prostate cancer worldwide. Several methods to determine the radi...

    Authors: Martin Kraihammer, Piotr Garnuszek, Andreas Bauman, Michael Maurin, Manuel Alejandre Lafont, Roland Haubner, Elisabeth von Guggenberg, Michael Gabriel and Clemens Decristoforo
    Citation: EJNMMI Radiopharmacy and Chemistry 2023 8:7
    Content type: Research article Published on:

  18. The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.

    Authors: Oliver C. Kiss, Peter J. H. Scott, Martin Behe, Ivan Penuelas, Jan Passchier, Ana Rey, Marianne Patt, Silvio Aime, Amir Jalilian, Peter Laverman, Zhen Cheng, Alain Faivre Chauvet, Jonathan Engle, Frederik Cleeren, Hua Zhu, Johnny Vercouillie…
    Citation: EJNMMI Radiopharmacy and Chemistry 2023 8:6
    Content type: Review Published on:

  19. [18F]fluoromisonidazole ([18F]FMISO, 1H-1-(3-[18F]fluoro-2-hydroxypropyl)-2-nitroimidazole) is a commonly used radiotracer for imaging hypoxic conditions in cells. Since hypoxia is prevalent in solid tumors, [18F...

    Authors: Torsten Kniess, Jörg Zessin, Peter Mäding, Manuela Kuchar, Oliver Kiss and Klaus Kopka
    Citation: EJNMMI Radiopharmacy and Chemistry 2023 8:5
    Content type: Research article Published on:

  20. [68Ga]Ga-PentixaFor is a promising radiotracer for positron emission tomography imaging of several human tumors overexpressing the chemokine receptor-4 (CXCR4). CXCR4 overexpression has been demonstrated in patie...

    Authors: Thomas Daniel, Clara Balouzet Ravinet, Jérôme Clerc, Rui Batista and Yvan Mouraeff
    Citation: EJNMMI Radiopharmacy and Chemistry 2023 8:4
    Content type: Research article Published on:

  21. Recently it has been identified a short peptide that showed allosteric antagonism against C–C motif chemokine receptor 2 (CCR2) expressed on inflammatory monocyte and macrophages. A 7-d-amino acid peptidic CCR2 i...

    Authors: Silvia Migliari, Maura Scarlattei, Giorgio Baldari and Livia Ruffini
    Citation: EJNMMI Radiopharmacy and Chemistry 2023 8:3
    Content type: Research article Published on:

  22. The molecular chaperone, Hsp90, is a key player in the protein quality control system that maintains homeostasis under cellular stress conditions. It is a homodimer with ATP-dependent activity, and is a promin...

    Authors: Romy Cools, Koen Vermeulen, Valeria Narykina, Renan C. F. Leitao and Guy Bormans
    Citation: EJNMMI Radiopharmacy and Chemistry 2023 8:2
    Content type: Research article Published on:

  24. 111In[In]-BnDTPA-trastuzumab-NLS is a radiopharmaceutical with theranostic applications for imaging and Meitner-Auger electron (MAE) radioimmunotherapy (RIT) of HER2-positive breast cancer (BC). Nuclear localizat...

    Authors: Conrad Chan, Vanessa Prozzo, Sadaf Aghevlian and Raymond M. Reilly
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:33
    Content type: Research Article Published on:

  25. Sodium iodide symporter (NIS) imaging by positron emission tomography (PET) is gaining traction in nuclear medicine, with an increasing number of human studies being published using fluorine-18 radiolabelled t...

    Authors: Dmitry Soloviev, Piotr Dzien, Agata Mackintosh, Gaurav Malviya, Gavin Brown and David Lewis
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:32
    Content type: Methodology Published on:

  26. 161Tb is a radiolanthanide with the potential to replace 177Lu in targeted radionuclide therapy. 161Tb is produced via the neutron irradiation of [160Gd]Gd2O3 targets, and must be purified from 160Gd and the deca...

    Authors: Scott W. McNeil, Michiel Van de Voorde, Chengcheng Zhang, Maarten Ooms, François Bénard, Valery Radchenko and Hua Yang
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:31
    Content type: Research article Published on:

  27. [18F]Flurpiridaz is a promising novel cardiac PET imaging tracer formed by the radiolabeling of pyridaben derivative with fluorine-18. Clinical studies on [18F]Flurpiridaz are currently at the phase III level for...

    Authors: Kurtulus Eryilmaz and Benan Kilbas
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:30
    Content type: Research article Published on:

  28. Radiopharmaceuticals are considered as regular medicinal products and therefore the same regulations as for non-radioactive medicinal products apply. However, specific aspects should be considered due to the r...

    Authors: Eline L. Hooijman, Carolline M. Ntihabose, Thom G. A. Reuvers, Julie Nonnekens, Else A. Aalbersberg, Jordy R. J. P. van de Merbel, Judith E. Huijmans, Stijn L. W. Koolen, Jeroen J. M. A. Hendrikx and Erik de Blois
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:29
    Content type: Methodology Published on:

  29. Quantification of actinium-225 through gamma counter measurements, when there is no secular equilibrium between actinium-225 and its gamma emitting daughters bismuth-213 and/or francium-221, can provide valuab...

    Authors: Dayana Castillo Seoane, Marijke De Saint-Hubert, Stephen Ahenkorah, Clarita Saldarriaga Vargas, Maarten Ooms, Lara Struelens and Michel Koole
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:28
    Content type: Research article Published on:

  30. The radiometal gallium-68 (68Ga) is increasingly used in diagnostic positron emission tomography (PET), with 68Ga-labeled radiopharmaceuticals developed as potential higher-resolution imaging alternatives to trad...

    Authors: Bryce J. B. Nelson, Jan D. Andersson, Frank Wuest and Sarah Spreckelmeyer
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:27
    Content type: Review Published on:

  31. 2-[18F]Fluoroethyltosylate ([18F]FEtOTs) is a well-known 18F-fluoroalkylating agent widely used to synthesize radiotracers for positron emission tomography. The widespread use of [18F]FEtOTs is due in part to its...

    Authors: Martha Sahylí Ortega Pijeira, Sofia Nascimento dos Santos, Yasniel Babi Araujo, André Luis Lapolli, Marcio Nardelli Wandermuren, Zalua Rodríguez Riera, Ivone Carvalho, Philip H. Elsinga and Emerson Soares Bernardes
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:26
    Content type: Research article Published on:

  32. The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.

    Authors: Jun Toyohara, Mohammed Al-Qahtani, Ya-Yao Huang, Emiliano Cazzola, Sergio Todde, Shozo Furumoto, Renata Mikolajczak, Clemens Decristoforo, Nic Gillings, Min Yang, Raymond Reilly, Adriano Duatti, Antonia Denkova, Ralf Schirrmacher, Giuseppe Carlucci, Yann Seimbille…
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:25
    Content type: Review Published on:

  33. [177Lu]Lu-PSMA is used for the treatment of metastatic castration-resistant prostate cancer. For in-house productions, quality control methods are essential for ensuring product quality, and thus patient safety. ...

    Authors: Else A. Aalbersberg, Tammie T. Cao, Martine M. Geluk-Jonker and Jeroen J. M. A. Hendrikx
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:24
    Content type: Research article Published on:

  36. With recent advances in novel approaches to cancer therapy and imaging, the application of theranostic techniques in personalised medicine has emerged as a very promising avenue of research inquiry in recent y...

    Authors: Alexander W. E. Sadler, Leena Hogan, Benjamin Fraser and Louis M. Rendina
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:21
    Content type: Review Published on:

  37. The recent development of quinoline-based radiotracers, which act as fibroblast activation protein inhibitors (FAPIs), has shown promising preclinical and clinical advantages. [68Ga]Ga-FAPI-46 is a new radiotrace...

    Authors: Ammar Alfteimi, Ulf Lützen, Alexander Helm, Michael Jüptner, Marlies Marx, Yi Zhao and Maaz Zuhayra
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:20
    Content type: Research article Published on:

  38. Myocardial perfusion imaging (MPI) is one of the most commonly performed investigations in nuclear medicine procedures. Due to the longer half-life of the emerging positron emitter copper-64 and its availabili...

    Authors: Norah AlHokbany, Ibrahim AlJammaz, Basem AlOtaibi, Yousif AlMalki, Bander AlJammaz and Subhani M. Okarvi
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:19
    Content type: Research article Published on:

  39. The development of radiopharmaceuticals requires extensive evaluation before they can be applied in a diagnostic or therapeutic setting in Nuclear Medicine. Chemical, radiochemical, and pharmaceutical paramete...

    Authors: Aruna Korde, Renata Mikolajczak, Petra Kolenc, Penelope Bouziotis, Hadis Westin, Mette Lauritzen, Michel Koole, Matthias Manfred Herth, Manuel Bardiès, Andre F. Martins, Antonio Paulo, Serge K. Lyashchenko, Sergio Todde, Sangram Nag, Efthimis Lamprou, Antero Abrunhosa…
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:18
    Content type: Review Published on:

  40. The efficient management of hospital radiopharmacy is very important for a good workflow in nuclear medicine and essential to ensure the correct traceability of the radiopharmaceuticals administered to patient...

    Authors: Jesús Luis Gómez Perales
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:17
    Content type: Research article Published on:

  41. Radionuclide therapy (RNT) has become a very important treatment modality for cancer nowadays. Comparing with other cancer treatment options, sufficient efficacy could be achieved in RNT with lower toxicity. β− e...

    Authors: Runze Wang, Bernard Ponsard, Hubert Wolterbeek and Antonia Denkova
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:16
    Content type: Research article Published on:

  42. Positron emission tomography (PET) is a powerful tool in medical imaging, especially in combination with the PET radionuclide fluorine-18 that possesses optimal characteristics. For labelling of biomolecules a...

    Authors: Carsten Sven Kramer, Luca Greiner, Klaus Kopka and Martin Schäfer
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:15
    Content type: Research article Published on:

  43. This review presents the results of a survey conducted by the International Atomic Energy Agency on cyclotrons and related infrastructure used for radionuclide and radiopharmaceutical production which are supp...

    Authors: Miguel A. Avila-Rodriguez, Amir R. Jalilian, Aruna Korde, David Schlyer, Mohammad Haji-Saeid, Jose Paez and Saul Perez-Pijuan
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:14
    Content type: Review Published on:

  44. Tissue hypoxia is a pathological condition characterized by reducing oxygen supply. Hypoxia is a hallmark of tumor environment and is commonly observed in many solid tumors. Non-invasive imaging techniques lik...

    Authors: Arian Pérez Nario, Jenilee Woodfield, Sofia Nascimento dos Santos, Cody Bergman, Melinda Wuest, Yasniel Babí Araújo, André Luis Lapolli, Frederick G. West, Frank Wuest and Emerson Soares Bernardes
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:13
    Content type: Research article Published on:

  45. Combining optical (fluorescence) imaging with nuclear imaging has the potential to offer a powerful tool in personal health care, where nuclear imaging offers in vivo functional whole-body visualization, and t...

    Authors: Anthony W. McDonagh, Brooke L. McNeil, Julie Rousseau, Ryan J. Roberts, Helen Merkens, Hua Yang, François Bénard and Caterina F. Ramogida
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:12
    Content type: Research article Published on:

  46. The increasing incidence of cancer over the years is one of the most challenging problems in healthcare. As cancer progresses, the recruitment of several immune cells is triggered. Infiltration of tumor-associ...

    Authors: Bruna Fernandes, Paula Kopschina Feltes, Carolina Luft, Luiza Reali Nazario, Cristina Maria Moriguchi Jeckel, Ines F. Antunes, Philip H. Elsinga and Erik F. J. de Vries
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:11
    Content type: Review Published on:

  47. Noninvasive molecular imaging using peptides and biomolecules labelled with positron emitters has become important for detection of cancer and other diseases with PET (positron emission tomography). The positr...

    Authors: Raphaël Hoareau, Tore Bach-Gansmo, Paul Cumming and Dag Erlend Olberg
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:10
    Content type: Research article Published on:

  48. The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development.

    Authors: Emerson Bernardes, Peter Caravan, R. Michael van Dam, Winnie Deuther-Conrad, Beverley Ellis, Shozo Furumoto, Benjamin Guillet, Ya-Yao Huang, Hongmei Jia, Peter Laverman, Zijing Li, Zhaofei Liu, Filippo Lodi, Yubin Miao, Lars Perk, Ralf Schirrmacher…
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:9
    Content type: Review Published on:

  49. Recent advances in nanotechnology have offered new hope for cancer detection, prevention, and treatment. Nanomedicine, a term for the application of nanotechnology in medical and health fields, uses nanopartic...

    Authors: Martha Sahylí Ortega Pijeira, Herlys Viltres, Jan Kozempel, Michal Sakmár, Martin Vlk, Derya İlem-Özdemir, Meliha Ekinci, Seshasai Srinivasan, Amin Reza Rajabzadeh, Eduardo Ricci-Junior, Luciana Magalhães Rebelo Alencar, Mohammed Al Qahtani and Ralph Santos-Oliveira
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:8
    Content type: Review Published on:

  50. Prosthetic approach for the radiolabeling of biologics with fluorine-18 is a robust strategy and has been employed for many years. It requires fast, biocompatible and selective reactions suited to these fragil...

    Authors: Mylène Richard, Françoise Hinnen and Bertrand Kuhnast
    Citation: EJNMMI Radiopharmacy and Chemistry 2022 7:7
    Content type: Research article Published on:
Submit manuscript

Follow

  • ISSN: 2365-421X (electronic)

Affiliated with

Neuer Inhalt